![]() |
| Analysts weigh Amgen osteoporosis drug safety (AP) |
|
RSS FEED
|
Shares of Amgen Inc. edged lower Wednesday as some analysts continued to question the safety profile of the biotechnology company's osteoporosis drug denosumab. Read more... |
||||||||||||
|
|
|||||||||||||
| Analysts weigh Amgen osteoporosis drug safety (AP) |
|
||
|
Site Map
|
Sitemap |

